Seeing Machines (LSE:SEE) has released the first instalment of a new Technical Paper series examining non-fatigue driver impairment, with an initial focus on the impact of alcohol. The initiative highlights how the company’s Driver Monitoring System (DMS) technology can provide real-time assessments of functional impairment, addressing shortcomings associated with traditional Blood Alcohol Concentration (BAC) measurements.
The company is working alongside industry specialists and academic institutions to further develop DMS capabilities for detecting impairment caused not only by alcohol but also by other substances, including cannabis. By broadening the scope of impairment detection, Seeing Machines aims to strengthen road safety outcomes and deliver more effective protection for drivers and other road users.
While Seeing Machines continues to benefit from a strong competitive position and supportive technical indicators, it faces ongoing challenges around profitability and cash generation. Strategic partnerships and favourable regulatory trends underpin longer-term growth prospects, although execution risks and valuation considerations remain in focus.
More about Seeing Machines
Seeing Machines is a global provider of vision-based monitoring solutions, founded in 2000 and headquartered in Australia. The company develops advanced Driver Monitoring Systems that deliver real-time insights into vehicle operator behaviour, enhancing safety across automotive, commercial fleet, off-road and aviation applications through the use of AI-driven algorithms, embedded processing and optical technologies.
Leave a Reply